The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Failing transcatheter aortic valve treated by transcatheter aortic valve in transcatheter aortic valve (TAV-in-TAV) implantation: valve safety versus valve durability

EuroIntervention 2014;10:1000. DOI: 10.4244/EIJV10I8A169

Department of Interventional Cardiology, McGill University Health Centre, Montreal, Quebec, Canada
We present the case of a 67-year-old male who presented with a degenerated 29 mm CoreValve (Medtronic, Minneapolis, MN, USA) five years after its successful implantation for severe bicuspid aortic valve stenosis (Online Figure 1). During the most recent hospitalisation, for an acute coronary syndrome, transoesophageal echocardiography (TEE) detected a new-onset severe transvalvular AR due to a prolapsing bioprosthetic valve leaflet (Figure 1A, Figure 1B, Figure 1F, Moving image 1). Signs and symptoms suggestive of endocarditis were absent. The Heart Team decided to proceed with a transcatheter aortic valve in transcatheter aortic valve (TAV-in-TAV) implantation using a 29 mm CoreValve prosthesis (Figure 1C). Contrast ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Self-expandable valve implantation within a failed balloon-expandable valve